Coverart for item
The Resource Novel developments in stem cell mobilization : focus on CXCR4, Stefan Fruehauf, W. Jens Zeller, Gary Calandra, editors, (electronic resource)

Novel developments in stem cell mobilization : focus on CXCR4, Stefan Fruehauf, W. Jens Zeller, Gary Calandra, editors, (electronic resource)

Label
Novel developments in stem cell mobilization : focus on CXCR4
Title
Novel developments in stem cell mobilization
Title remainder
focus on CXCR4
Statement of responsibility
Stefan Fruehauf, W. Jens Zeller, Gary Calandra, editors
Contributor
Subject
Language
eng
Dewey number
616.02/774
Index
index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Fruehauf, Stefan
  • Zeller, W. J
  • Calandra, Gary
http://library.link/vocab/subjectName
  • Stem cells
  • Cancer
Label
Novel developments in stem cell mobilization : focus on CXCR4, Stefan Fruehauf, W. Jens Zeller, Gary Calandra, editors, (electronic resource)
Instantiates
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
  • Part 2.
  • Clinical Studies on Stem Cell Mobilization
  • Front matter
  • Early Studies of AMD3100/Plerixafor in Healthy Volunteers
  • The Current Role of Plerixafor in Stem Cell Mobilization for Hematopoietic Stem Cell Transplantation
  • Experience with Apheresis Procedures After Plerixafor Mobilisation
  • Influence of Different Stem Cell Mobilization Strategies on Graft Composition and Outcome of Autologous or Allogeneic Transplantation
  • Relevance and Clinical Implications of Tumor Cell Mobilization in Autologous Transplantation of Multiple Myeloma and Non-Hodgkin's Lymphoma
  • Plerixafor: Data from the Compassionate Use Program
  • Stem Cell Mobilization with Chemomobilization Plus Plerixafor in Hard-to-Mobilize Patients: The Experience at Kuopio University Hospital, Finland
  • Part 1.
  • Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization
  • Mobilization with Chemotherapy + G-CSF + Plerixafor in Europe: The Italian Experience
  • Experience with Plerixafor in Poor Mobilizers
  • CXCR4 Antagonists
  • Part 3.
  • CXCR4 Antagonists for Treatment of Leukemias and Solid Tumors
  • Front matter
  • Application of CXCR4 Inhibitors in Leukemia
  • CXCR4 Antagonists for the Treatment of CML
  • Targeting CXCR4 in Chronic Lymphocytic Leukemia: Preclinical Rationale and Early Clinical Experience
  • Basic Science and Experimental Studies on Stem Cell Mobilization
  • CXCR4-Blockade for Treatment of Breast Cancer
  • Molecular Imaging of CXCR4 Receptor Expression in Tumors
  • Part 4.
  • Novel applications
  • Potential Use of CXCR4 Antagonists to Mobilize Endothelial and Mesenchymal Stem Cells
  • Strategies to Enhance Hematopoietic Stem Cell Engraftment Following Transplantation
  • Mobilization for Gene Therapy
  • Preclinical Experience with AMD3100 for Mobilization of Hematopoietic Stem and Progenitor Cells
  • Molecular Pharmacology of CXCR4 Inhibition
  • Combination Strategies for Stem Cell Mobilization Targeting CXCR4 and S1P Receptors
  • Should We Stay or Should We Go Now?
  • Cell Adhesion and Mobilization Pathways of Hematopoietic Cells
  • Role of the CXCR4/CXCL12 Axis in Hematopoietic Stem Cell Trafficking
Control code
ocn777947224
Dimensions
unknown
Extent
1 online resource (xiv, 496 p.)
File format
unknown
Form of item
online
Isbn
9781461419600
Isbn Type
(electronic bk.)
Level of compression
unknown
Other control number
10.1007/978-1-4614-1960-0
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)777947224
Label
Novel developments in stem cell mobilization : focus on CXCR4, Stefan Fruehauf, W. Jens Zeller, Gary Calandra, editors, (electronic resource)
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
  • Part 2.
  • Clinical Studies on Stem Cell Mobilization
  • Front matter
  • Early Studies of AMD3100/Plerixafor in Healthy Volunteers
  • The Current Role of Plerixafor in Stem Cell Mobilization for Hematopoietic Stem Cell Transplantation
  • Experience with Apheresis Procedures After Plerixafor Mobilisation
  • Influence of Different Stem Cell Mobilization Strategies on Graft Composition and Outcome of Autologous or Allogeneic Transplantation
  • Relevance and Clinical Implications of Tumor Cell Mobilization in Autologous Transplantation of Multiple Myeloma and Non-Hodgkin's Lymphoma
  • Plerixafor: Data from the Compassionate Use Program
  • Stem Cell Mobilization with Chemomobilization Plus Plerixafor in Hard-to-Mobilize Patients: The Experience at Kuopio University Hospital, Finland
  • Part 1.
  • Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization
  • Mobilization with Chemotherapy + G-CSF + Plerixafor in Europe: The Italian Experience
  • Experience with Plerixafor in Poor Mobilizers
  • CXCR4 Antagonists
  • Part 3.
  • CXCR4 Antagonists for Treatment of Leukemias and Solid Tumors
  • Front matter
  • Application of CXCR4 Inhibitors in Leukemia
  • CXCR4 Antagonists for the Treatment of CML
  • Targeting CXCR4 in Chronic Lymphocytic Leukemia: Preclinical Rationale and Early Clinical Experience
  • Basic Science and Experimental Studies on Stem Cell Mobilization
  • CXCR4-Blockade for Treatment of Breast Cancer
  • Molecular Imaging of CXCR4 Receptor Expression in Tumors
  • Part 4.
  • Novel applications
  • Potential Use of CXCR4 Antagonists to Mobilize Endothelial and Mesenchymal Stem Cells
  • Strategies to Enhance Hematopoietic Stem Cell Engraftment Following Transplantation
  • Mobilization for Gene Therapy
  • Preclinical Experience with AMD3100 for Mobilization of Hematopoietic Stem and Progenitor Cells
  • Molecular Pharmacology of CXCR4 Inhibition
  • Combination Strategies for Stem Cell Mobilization Targeting CXCR4 and S1P Receptors
  • Should We Stay or Should We Go Now?
  • Cell Adhesion and Mobilization Pathways of Hematopoietic Cells
  • Role of the CXCR4/CXCL12 Axis in Hematopoietic Stem Cell Trafficking
Control code
ocn777947224
Dimensions
unknown
Extent
1 online resource (xiv, 496 p.)
File format
unknown
Form of item
online
Isbn
9781461419600
Isbn Type
(electronic bk.)
Level of compression
unknown
Other control number
10.1007/978-1-4614-1960-0
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)777947224

Library Locations

    • InternetBorrow it
      Albany, Auckland, 0632, NZ
Processing Feedback ...